0001140361-12-025912.txt : 20120516 0001140361-12-025912.hdr.sgml : 20120516 20120516193026 ACCESSION NUMBER: 0001140361-12-025912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120430 FILED AS OF DATE: 20120516 DATE AS OF CHANGE: 20120516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooper Jeffrey H CENTRAL INDEX KEY: 0001301173 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 12850100 MAIL ADDRESS: STREET 1: BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0305 4 2012-04-30 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001301173 Cooper Jeffrey H C/O BIOMARIN PHARMACEUTICAL INC. 10 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 SVP, Chief Financial Officer Common Stock 2012-04-30 2012-04-30 5 A 0 985 19.346 A 41089 D Common Stock 2012-05-14 2012-05-14 4 M 0 15000 26.49 A 56089 D Common Stock 2012-05-14 2012-05-14 4 M 0 6500 21.51 A 62589 D Common Stock 2012-05-14 2012-05-14 4 M 0 3750 14.39 A 66339 D Common Stock 2012-05-14 2012-05-14 4 S 0 25250 38.0878 D 41089 D Stock Option (right to buy) 26.49 2012-05-14 2012-05-14 4 M 0 15000 26.49 D 2011-11-12 2021-05-11 Common Stock 15000 164042 D Stock Option (right to buy) 21.51 2012-05-14 2012-05-14 4 M 0 6500 21.51 D 2010-11-12 2020-05-11 Common Stock 6500 157542 D Stock Option (right to buy) 14.39 2012-05-14 2012-05-14 4 M 0 3750 14.39 D 2009-11-12 2019-05-11 Common Stock 3750 153792 D The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP period of November 1,2011 to April 30, 2012. Transaction made pursuant to a Rule 10b5-1 Trading plan executed March 6, 2012. The price in Column 4 is a weighted average price. The prices actually received ranged from $37.31 to $38.6325. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Original option grant vested 6/48ths on November 12, 2011 and 1/48th on the 12th of every month thereafter. Original option grant vested 6/48ths on November 12, 2010 and 1/48th on the 12th of every month thereafter. Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter. /s/ Laura Randall Woodhead, Attorney-in-Fact 2012-05-16